Vestjysk Bank A/S
13.1.2021 18:27:37 CET | Globenewswire | Press release
13 January 2021
With reference to the company announcement previously issued by Vestjysk Bank A/S ("Vestjysk Bank") regarding the course of Vestjysk Bank's extraordinary general meeting of 13 January 2021, it is hereby announced that Vestjysk Bank has received notification of the result of the extraordinary general meeting of Den Jyske Sparekasse A/S ("Den Jyske Sparekasse").
The general meeting of Den Jyske Sparekasse has also adopted the proposal to execute the merger between Vestjysk Bank and Den Jyske Sparekasse.
The only outstanding condition for the merger between Vestjysk Bank and Den Jyske Sparekasse is the receipt of the Danish Financial Supervisory Authority's final approval for the proposed merger in accordance with section 204 of the Danish Financial Business Act, which is expected tomorrow, Thursday 14 January 2021, where the registration at the Danish Business Authority is also expected to be completed.
13 January 2021
Vestjysk Bank A/S
The Board of directors
Vestjysk Bank A/S
Torvet 4-5
DK-7620 Lemvig
Telephone +45 96 63 20 00
CVR-nr. 34 63 13 28
www.vestjyskbank.dk
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Rocket Lab Corporation28.3.2026 11:39:53 CET | Press release
Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency
Vivoryon Therapeutics N.V.28.3.2026 07:00:00 CET | Press release
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
